Natasha Kyprianou

9.4k total citations · 1 hit paper
135 papers, 7.5k citations indexed

About

Natasha Kyprianou is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Natasha Kyprianou has authored 135 papers receiving a total of 7.5k indexed citations (citations by other indexed papers that have themselves been cited), including 68 papers in Pulmonary and Respiratory Medicine, 63 papers in Molecular Biology and 37 papers in Oncology. Recurrent topics in Natasha Kyprianou's work include Prostate Cancer Treatment and Research (60 papers), Prostate Cancer Diagnosis and Treatment (19 papers) and TGF-β signaling in diseases (16 papers). Natasha Kyprianou is often cited by papers focused on Prostate Cancer Treatment and Research (60 papers), Prostate Cancer Diagnosis and Treatment (19 papers) and TGF-β signaling in diseases (16 papers). Natasha Kyprianou collaborates with scholars based in United States, Sweden and United Kingdom. Natasha Kyprianou's co-authors include John T. Isaacs, Hugh F. English, Shinichi Sakamoto, Craig Horbinski, Patrick J. Hensley, Zheng Cao, Nancy E. Davidson, Hong Pu, Sarah K. Martin and Mari Nakazawa and has published in prestigious journals such as PLoS ONE, JNCI Journal of the National Cancer Institute and Cancer Research.

In The Last Decade

Natasha Kyprianou

132 papers receiving 7.4k citations

Hit Papers

1 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Activation of Programmed Cell Death in the Rat Ventral Prostate after Castration*

1988 604 citations Natasha Kyprianou, John T. Isaacs profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Natasha Kyprianou United States	49	3.9k	2.7k	2.0k	1.7k	719	135	7.5k
Ilsa M. Coleman United States	46	3.8k 1.0×	4.0k 1.5×	2.2k 1.1×	2.2k 1.3×	802 1.1×	111	7.8k
Joanne Edwards United Kingdom	53	4.6k 1.2×	3.0k 1.1×	3.0k 1.5×	2.3k 1.4×	661 0.9×	264	9.1k
Samuel R. Denmeade United States	56	4.4k 1.1×	4.3k 1.6×	2.6k 1.3×	2.2k 1.3×	1.1k 1.6×	223	9.8k
Hing Y. Leung United Kingdom	53	5.3k 1.3×	2.1k 0.8×	1.6k 0.8×	1.8k 1.0×	279 0.4×	204	7.8k
Colm Morrissey United States	48	3.8k 1.0×	2.9k 1.1×	2.2k 1.1×	2.5k 1.5×	317 0.4×	146	7.2k
Eva Corey United States	50	3.8k 1.0×	3.9k 1.4×	3.3k 1.7×	1.8k 1.1×	412 0.6×	194	7.9k
Lisa M. Butler Australia	41	4.0k 1.0×	1.8k 0.6×	1.6k 0.8×	2.1k 1.2×	370 0.5×	149	6.7k
Christopher P. Evans United States	58	5.1k 1.3×	4.9k 1.8×	1.8k 0.9×	3.6k 2.1×	731 1.0×	250	10.3k
Karen E. Knudsen United States	61	6.3k 1.6×	4.1k 1.5×	4.0k 2.1×	2.5k 1.5×	531 0.7×	169	11.1k
Srinivasan Yegnasubramanian United States	52	6.3k 1.6×	3.8k 1.4×	1.6k 0.8×	2.7k 1.6×	412 0.6×	166	9.9k

Countries citing papers authored by Natasha Kyprianou

Since Specialization

Citations

This map shows the geographic impact of Natasha Kyprianou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Natasha Kyprianou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Natasha Kyprianou more than expected).

Fields of papers citing papers by Natasha Kyprianou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Natasha Kyprianou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Natasha Kyprianou. The network helps show where Natasha Kyprianou may publish in the future.

Co-authorship network of co-authors of Natasha Kyprianou

This figure shows the co-authorship network connecting the top 25 collaborators of Natasha Kyprianou. A scholar is included among the top collaborators of Natasha Kyprianou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Natasha Kyprianou. Natasha Kyprianou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Urbanucci, Alfonso, et al.. (2024). Link between circadian rhythm and benign prostatic hyperplasia (BPH)/lower urinary tract symptoms (LUTS). The Prostate. 84(5). 417–425. 5 indexed citations

Hensley, Patrick J., Jieming Li, Yang Zhang, et al.. (2020). Integrin-associated CD151 is a suppressor of prostate cancer progression.. PubMed Central. 12(4). 1428–1442. 10 indexed citations

Hensley, Patrick J., et al.. (2019). Predictive value of phenotypic signatures of bladder cancer response to cisplatin-based neoadjuvant chemotherapy. Urologic Oncology Seminars and Original Investigations. 37(9). 572.e1–572.e11. 12 indexed citations

Martin, Sarah K., et al.. (2015). Multinucleation and Mesenchymal-to-Epithelial Transition Alleviate Resistance to Combined Cabazitaxel and Antiandrogen Therapy in Advanced Prostate Cancer. Cancer Research. 76(4). 912–926. 73 indexed citations

Martin, Sarah K., et al.. (2014). Cofilin Drives Cell-Invasive and Metastatic Responses to TGF-β in Prostate Cancer. Cancer Research. 74(8). 2362–2373. 83 indexed citations

Martin, Sarah K., Carmen A. Bañuelos, Marianne D. Sadar, & Natasha Kyprianou. (2014). N‐terminal targeting of androgen receptor variant enhances response of castration resistant prostate cancer to taxane chemotherapy. Molecular Oncology. 9(3). 628–639. 50 indexed citations

Liu, Yinxing, et al.. (2014). The tumor suppressor prostate apoptosis response-4 (Par-4) is regulated by mutant IDH1 and kills glioma stem cells. Acta Neuropathologica. 128(5). 723–732. 12 indexed citations

Kahn, Barbara E., et al.. (2014). Androgen Receptor as a Driver of Therapeutic Resistance in Advanced Prostate Cancer. International Journal of Biological Sciences. 10(6). 588–595. 86 indexed citations

Fiandalo, Michael V., Steven R. Schwarze, & Natasha Kyprianou. (2013). Proteasomal regulation of caspase-8 in cancer cell apoptosis. APOPTOSIS. 18(6). 766–776. 18 indexed citations

10.

Horbinski, Craig, et al.. (2010). Tubulin-Targeting Chemotherapy Impairs Androgen Receptor Activity in Prostate Cancer. Cancer Research. 70(20). 7992–8002. 288 indexed citations

11.

Sakamoto, Shinichi, Richard O. McCann, Rajiv Dhir, & Natasha Kyprianou. (2010). Talin1 Promotes Tumor Invasion and Metastasis via Focal Adhesion Signaling and Anoikis Resistance. Cancer Research. 70(5). 1885–1895. 174 indexed citations

12.

Horbinski, Craig, et al.. (2010). Live Free or Die. American Journal Of Pathology. 177(3). 1044–1052. 78 indexed citations

13.

Pu, Hong, et al.. (2009). Dysfunctional Transforming Growth Factor-β Receptor II Accelerates Prostate Tumorigenesis in the TRAMP Mouse Model. Cancer Research. 69(18). 7366–7374. 47 indexed citations

14.

Schwarze, Steven R., et al.. (2008). Intracellular death platform steps‐in: Targeting prostate tumors via endoplasmic reticulum (ER) apoptosis. The Prostate. 68(15). 1615–1623. 18 indexed citations

15.

Fukada, Kei, et al.. (2006). Prohibitin and Cofilin Are Intracellular Effectors of Transforming Growth Factor β Signaling in Human Prostate Cancer Cells. Cancer Research. 66(17). 8640–8647. 92 indexed citations

16.

Bhaskaran, Shylesh, et al.. (2006). Akt- and CREB-Mediated Prostate Cancer Cell Proliferation Inhibition by Nexrutine, a Phellodendron amurense Extract. Neoplasia. 8(6). 523–533. 56 indexed citations

17.

Sheng, Shijie, et al.. (2005). Maspin sensitizes prostate cancer cells to doxazosin-induced apoptosis. Oncogene. 24(34). 5375–5383. 32 indexed citations

18.

Partin, James, Ian E. Anglin, & Natasha Kyprianou. (2003). Quinazoline-based α1-adrenoceptor antagonists induce prostate cancer cell apoptosis via TGF-β signalling and IκBα induction. British Journal of Cancer. 88(10). 1615–1621. 92 indexed citations

19.

D’Souza, Brendan, Feodor Berdichevsky, Natasha Kyprianou, & Joyce Taylor‐Papadimitriou. (1993). Collagen-induced morphogenesis and expression of the alpha 2-integrin subunit is inhibited in c-erbB2-transfected human mammary epithelial cells.. PubMed. 8(7). 1797–806. 64 indexed citations

20.

Kyprianou, Natasha & John T. Isaacs. (1987). Quantal relationship between prostatic dihydrotestosterone and prostatic cell content: Critical threshold concept. The Prostate. 11(1). 41–50. 77 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact